These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 746466)

  • 41. Intravenous magnesium for cardiac arrhythmias: jack of all trades.
    Ho KM
    Magnes Res; 2008 Mar; 21(1):65-8. PubMed ID: 18557136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disopyramide--an effective treatment for lignocaine resistant ventricular dysrhythmias.
    Green AG
    Scott Med J; 1979 Jan; 24(1):21-4. PubMed ID: 91197
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Anti-arrhythmic action of disopyramide in comparison with that of quinidine].
    Poletti T; Aquaro G; D'Arrigo A; Pavia M
    Boll Soc Ital Cardiol; 1971; 16(9):591-600. PubMed ID: 5150385
    [No Abstract]   [Full Text] [Related]  

  • 44. [Efficacy and tolerability of sustained-release disopyramide in the treatment of cardiac arrhythmia. Results of a study with 593 patients].
    Lekieffre J; Vaur L; Kacet S; Lacroix D
    Ann Cardiol Angeiol (Paris); 1993 Feb; 42(2):115-9. PubMed ID: 8494319
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Evaluation of the efficacy of anti-arrhythmia agents in hyperkinetic ventricular arrhythmia].
    Bracchetti D; Mantovani B; Naccarella F; Lombardi G; Palmieri M
    Boll Soc Ital Cardiol; 1980; Suppl():117-23. PubMed ID: 7349604
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical studies of Norpace (Part IV).
    Jutzy RV
    Angiology; 1975 Jan; 26(1 Pt 2):138-9. PubMed ID: 803798
    [No Abstract]   [Full Text] [Related]  

  • 47. Anti-arrhythmic and haemodynamic effects of intravenous and oral disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    J Int Med Res; 1976; 4(1 Suppl):90-5. PubMed ID: 1026537
    [No Abstract]   [Full Text] [Related]  

  • 48. Disopyramide.
    Morady F; Scheinman MM; Desai J
    Ann Intern Med; 1982 Mar; 96(3):337-43. PubMed ID: 7036817
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Disopyramide in heart arrhythmias].
    Pellegrino L; Di Michele A; Prencipe D
    Boll Soc Ital Cardiol; 1972; 17(8):617-25. PubMed ID: 4655948
    [No Abstract]   [Full Text] [Related]  

  • 50. Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1978 May; 15(5):331-68. PubMed ID: 350555
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical studies of Norpace (Part V).
    Cook WR
    Angiology; 1975 Jan; 26(1 Pt 2):140-1. PubMed ID: 1115401
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical evaluation of antiarrhythmic effects of disopyramide by multiclinical controlled double-blind methods.
    Kimura E; Mashima S; Tanaka T
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):338-43. PubMed ID: 7409935
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The pharmacology of Norpace.
    Dean RR
    Angiology; 1975 Jan; 26(1 Pt 2):67-84. PubMed ID: 1115403
    [No Abstract]   [Full Text] [Related]  

  • 54. [Electrophysiological testing of multiple antiarrhythmic drugs in patients with paroxysmal supraventricular tachycardia after chronic oral administration].
    Nishino T
    Hokkaido Igaku Zasshi; 1989 Nov; 64(6):738-48. PubMed ID: 2606448
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effect of intravenous disopyramide in supraventricular paroxysmal tachycardia refractory to vagal maneuvers].
    Romero-Ayala LC; Soní J
    Arch Inst Cardiol Mex; 1983; 53(2):147-51. PubMed ID: 6882095
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Electrophysiological interrelations of disopyramide with atropine].
    González Maqueda I; García Fernández F; Martin Jadraque L; López Sendon JL; Coma Canella I
    Rev Esp Cardiol; 1979; 32(2):127-31. PubMed ID: 472418
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of oral disopyramide phosphate on induction of paroxysmal supraventricular tachycardia.
    Swiryn S; Bauernfeind RA; Wyndham CR; Dhingra RC; Palileo E; Strasberg B; Rosen KM
    Circulation; 1981 Jul; 64(1):169-75. PubMed ID: 7237716
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Intravenously disopyramide phosphate administration for treatment of arrhythmias].
    Aquaro G; Belli R; Pavia M; Rey L; Ravera A; Possavino G; Idone P
    G Ital Cardiol; 1982; 12(7):509-19. PubMed ID: 7169147
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of disopyramide phosphate in the treatment of refractory ventricular arrhythmias.
    Meyers DG; Mohiuddin SM
    Nebr Med J; 1980 May; 65(5):123-5. PubMed ID: 7383223
    [No Abstract]   [Full Text] [Related]  

  • 60. Long-term use of controlled-release disopyramide in patients with severe ventricular arrhythmias.
    Paulk EA
    Angiology; 1987 Feb; 38(2 Pt 2):198-204. PubMed ID: 3103494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.